{"url_path":"/sec/asbpw/8-k/2026-05-14/item-5-03","section_key":"item-5-03","section_title":"Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1847345/0001493152-26-023069-index.html","accession_number":"0001493152-26-023069","cik":"0001847345","ticker":"ASBP","issuer_name":"Aspire Biopharma Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1847345/0001493152-26-023069-index.html","primary_entity_key":"0001847345","primary_entity_name":"Aspire Biopharma Holdings, Inc."},"word_count":240,"has_tables":true,"body_markdown":"**Item\n5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.**\n\n \n\nOn\nMay 11, 2026, Aspire Biopharma Holdings, Inc. (the “Company”) filed with the Secretary of State of the State of Delaware\na Certificate of Amendment to the Company’s Certificate of Incorporation (the “Certificate of Amendment”).\n\n \n\nPursuant\nto the Certificate of Amendment, the Company amended Article Fourth of its Certificate of Incorporation to effect a 1-for-30 reverse\nstock split of the Company’s issued and outstanding common stock (the “Reverse Split”). The Reverse Split will become\neffective as of New York time on the effective date set forth in the Certificate of Amendment.\n\n \n\nAs\na result of the Reverse Split, every thirty (30) shares of the Company’s issued and outstanding common stock immediately prior\nto the effective time will automatically be combined and converted into one (1) share of common stock. No fractional shares will be issued\nin connection with the Reverse Split, and any fractional shares resulting from the Reverse Split will be rounded up to the nearest whole\nshare.\n\n \n\nThe\ntrading symbol for the Common Stock will remain “ABSP,” and the new CUSIP number of the Common Stock following the Reverse\nStock Split is 738920305.\n\n \n\nThe\nforegoing description of the Certificate of Amendment is qualified in its entirety by reference to the full text of the Certificate of\nAmendment, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and incorporated herein by reference."}